China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

Rang in aandelen #2914
China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent... China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. is a prominent pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of medicinal products. Its operations span both the People's Republic of China and international markets, additionally providing various health-related services. The company's extensive product line includes a wide range of over-the-counter (OTC) medications addressing common conditions such as colds, skin issues, gastrointestinal complaints, coughs, and needs in orthopedics and pediatrics. It also provides prescription drugs, with a focus on areas like traditional Chinese medicine, oncology, cardiovascular and cerebrovascular health, digestive system disorders, orthopedics, and pediatrics. Further offerings comprise Chinese medicine injections, specialized formula granules, and anti-infective agents. These products are often marketed under popular brand families, notably 999 family medicine, Sanjiuweitai series, 999 Ganmaoling series, and 999 dermatitis series. Founded in 1999 and headquartered in Shenzhen, PRC, the company initially operated as Sanjiu Pharmaceutical Co., Ltd. before rebranding to its current name in February 2010. It functions as a subsidiary under the umbrella of China Resources (Holdings) Co., Ltd.
Aandeelprijs
$3.74
Marktkapitalisatie
$6.23B
Verandering (1 dag)
-2.11%
Verandering (1 jaar)
-8.54%
Land
CN
Handel China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)

Categorie

Healthcare
Omzet van China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (000999)
Omzet in Jun 2026 TTM: $4.76B
Volgens de laatste financiële rapporten van China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. bedraagt de huidige omzet van het bedrijf (TTM) $4.76B. In 2024 behaalde het bedrijf een omzet van $3.78B een stijging ten opzichte van de omzet in het jaar 2023, die $3.49B bedroeg. De omzet is het totale bedrag aan inkomsten dat een bedrijf genereert door de verkoop van goederen of diensten. In tegenstelling tot de winst worden er geen kosten afgetrokken.
Omzetgeschiedenis van China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. van 2001 tot 2026
Omzet aan het einde van elk jaar
Jaar Omzet Wijzigen
2026 (TTM) $4.76B 5.44%
2025 $4.52B 19.38%
2024 $3.78B 8.26%
2023 $3.49B 42.90%
2022 $2.45B 17.16%
2020 $2.09B -1.74%
2019 $2.12B 8.83%
2018 $1.95B 14.22%
2017 $1.71B 32.12%
2016 $1.29B 6.34%
2015 $1.22B 3.56%
2014 $1.17B -2.29%
2013 $1.20B 7.98%
2012 $1.11B 28.69%
2011 $865.22M 30.83%
2010 $661.34M -6.96%
2009 $710.79M 12.37%
2008 $632.54M 35.93%
2007 $465.35M 26.67%
2006 $367.39M -0.13%
2005 $367.88M 23.67%
2004 $297.46M -7.95%
2003 $323.17M 23.51%
2002 $261.66M 15.95%
2001 $225.66M 0.00%
Omzet van vergelijkbare bedrijven of concurrenten
Bedrijf Omzet Omzetverschil Land
$23.54B 394.15%
DE
$23.73B 398.34%
DE
$29.24B 513.92%
JP
$5.85B 22.80%
CH
$6.34B 33.16%
IN